LIQUIDIA CORP (NASDAQ:LQDA) Emerges as a High-Growth Momentum and Trend Template Candidate

For investors looking to join strong growth potential with systematic trend-following, a plan mixing Mark Minervini’s strict technical rules with an emphasis on fundamental momentum can be an effective way. This process first uses Minervini’s Trend Template to confirm a stock is in a clear, strong uptrend, filtering out poor or consolidating stocks. It then adds a High Growth Momentum (HGM) filter, which checks a company’s earnings and sales growth, estimate changes, and profit margin direction. The aim is to find leading stocks that are both technically sound and supported by bettering business fundamentals, providing a two-part perspective for seizing major market moves.

One present candidate found by this combined filter is LIQUIDIA CORP (NASDAQ:LQDA), a biopharmaceutical company working on rare cardiopulmonary diseases.

A Clear Minervini Trend Template Arrangement

Fundamentally, Minervini’s plan requires that a stock’s price action shows clear strength and agreement across different time periods. The Trend Template’s moving average conditions are made to verify a stock is in a Stage 2 climb, where most of its gains usually happen. LIQUIDIA’s chart now shows this standard agreement, hitting the main technical marks:

• Price Above Key Averages: The stock trades at $34.49, well above its rising 50-day ($29.95), 150-day ($23.58), and 200-day ($21.40) simple moving averages (SMAs). This meets the main condition of trading in a clear uptrend.
• Moving Average Order: The 50-day SMA is above both the 150-day and 200-day SMAs, and the 150-day SMA is above the 200-day SMA. This positive order signals increasing momentum across short, medium, and long-term periods.
• Nearness to Highs: With a 52-week high of $36.41, LQDA’s current price is within 5.3% of that top. Minervini notes that real market leaders trade close to their highs, not staying far below them.
• Large Gain from Lows: The stock’s price is about 206% above its 52-week low of $11.26, showing strong recovery and trend force.
• Better Relative Strength: With a ChartMill Relative Strength (CRS) score of 98.45, LQDA is doing better than almost 99% of all stocks in the market over the past year. High relative strength is a key part of the plan, finding sector and market leaders.

This combination of elements forms a view of a stock in a strong, continuing uptrend, exactly the kind of technical setting Minervini’s plan aims to use.

The High Growth Momentum Driver

While a good chart is necessary, Minervini’s full SEPA (Specific Entry Point Analysis) plan gives similar importance to fundamental growth. The High Growth Momentum score looks at the financial numbers that often drive lasting price gains. LIQUIDIA’s profile displays several strong growth signs that support its place in such a filter.

• Outstanding Revenue Growth: The most notable number is the trailing twelve-month (TTM) revenue growth of 343.4%. More significantly, this growth is increasing quickly on a quarterly basis. Last quarter’s sales jumped 1,121.7% year-over-year, and forecasts for the next quarter predict growth over 2,828%. This type of sharp sales change is a standard trigger for a large revaluation.
• Analyst Confidence and Estimate Changes: Analyst opinion is becoming strongly positive, a main HGM condition. The average estimate for next year’s earnings has been raised by 53.3% over the last three months, while revenue estimates for next year have been raised by 116.4%. Such large upward changes often come before continued institutional purchasing.
• Earnings Path: Although the company is not yet profitable on a net basis (EPS TTM is -$1.44), the direction is getting better. The latest quarter showed EPS growth of 86.7% year-over-year, and the next quarter is expected to grow by 143.9%. The move toward profitability is an important story for high-growth biotech stocks.
• Good Estimate Beat Record: The company has surpassed revenue estimates in two of the last four quarters, with an average beat of 63.3%. This record of beating expectations creates trust with investors.

These numbers show that LQDA’s strong price trend is not happening alone; it is backed by a fundamental story of fast commercial advancement and growing analyst belief.

Technical Condition and Setup Value

Beyond the basic rules of the Trend Template, ChartMill’s own analysis gives a more detailed view of the stock’s technical condition and trade setup possibility.

The platform gives LIQUIDIA a top Technical Rating of 10 out of 10, showing strong performance across all checked time periods and measures. The report states both short-term and long-term trends are positive, and the stock is doing better than 93% of its peers in the Pharmaceuticals industry. This matches well with the Minervini idea of concentrating on sector leaders.

From an entry viewpoint, the Setup Quality rating is a good 7. The analysis states the stock is now in a pause within its uptrend, showing a "bull flag" shape with decreasing volatility and lower volume, a positive sign that can offer a possible lower-risk entry chance. The report finds clear support near the $32.58 level and resistance around $35.80.

You can review the full, detailed technical analysis for LQDA here.

A Candidate for the Growth-Oriented Trend Follower

In conclusion, LIQUIDIA CORP offers a case where a strict, rules-driven filtering process finds agreement between technical momentum and fundamental growth. The stock meets the systematic checklist of Minervini’s Trend Template, confirming its position in a solid market uptrend. At the same time, its rapid revenue growth, positive estimate changes, and bettering earnings path supply the fundamental "reason" that Minervini’s SEPA plan needs to support a continuing climb.

For investors using this mixed growth-and-trend plan, LQDA stands as the kind of candidate that deserves more study: a leader in its sector, advancing on the charts, with a business story showing sharp improvement.

Interested in finding other stocks that match this High Growth Momentum + Trend Template profile? You can run the filter yourself using this link to see the present market candidates.

Disclaimer: This article is for informational and educational purposes only. It is not a recommendation to buy or sell any security. The analysis is based on present data and a specific quantitative plan; past performance is not a guide to future results. Always do your own complete research, think about your personal risk tolerance, and talk with a qualified financial advisor before making any investment decisions.